Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
46,82 USD | +2,99% | -0,40% | -2,09% |
Omzet 2024 * | 515 mln. 477 mln. | Omzet 2025 * | 633 mln. 587 mln. | Marktkapitalisatie | 3,85 mld. 3,57 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -532 mln. -493 mln. | Nettowinst (verlies) 2025 * | -453 mln. -420 mln. | EV/omzet 2024 * | 6,84 x |
Nettoliquiditeiten 2024 * | 334 mln. 310 mln. | Nettoliquiditeiten 2025 * | 298 mln. 277 mln. | EV/omzet 2025 * | 5,62 x |
K/w-verhouding 2024 * |
-7,26
x | K/w-verhouding 2025 * |
-9,08
x | Werknemers | 1.276 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 95,88% |
Recentste transcriptie over Ultragenyx Pharmaceutical Inc.
1 dag | +2,99% | ||
1 week | -0,40% | ||
Lopende maand | -9,47% | ||
1 maand | -12,75% | ||
3 maanden | -4,82% | ||
6 maanden | +26,85% | ||
Lopend jaar | -2,09% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Emil Kakkis
FOU | Founder | 63 | 22-04-10 |
Howard Horn
DFI | Director of Finance/CFO | 47 | 16-10-23 |
Eric Crombez
CTO | Chief Tech/Sci/R&D Officer | - | 01-11-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Deborah Dunsire
BRD | Director/Board Member | 61 | 06-04-17 |
Emil Kakkis
FOU | Founder | 63 | 22-04-10 |
Daniel Welch
CHM | Chairman | 66 | 08-04-15 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
2.21% | 1 M€ | -.--% | - | |
0.82% | 4 M€ | +20,15% | ||
0.43% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
27-03-24 | 46,82 | +2,99% | 551 352 |
26-03-24 | 45,46 | +0,09% | 362 335 |
25-03-24 | 45,42 | -0,94% | 442 715 |
22-03-24 | 45,85 | -1,71% | 403 665 |
21-03-24 | 46,65 | -0,77% | 473 570 |
uitgestelde koers Nasdaq, 27 maart 2024 om 21:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,09% | 3,85 mld. | |
+2,56% | 108 mld. | |
+10,02% | 104 mld. | |
+7,83% | 23,66 mld. | |
-11,91% | 22,1 mld. | |
-3,29% | 19,71 mld. | |
-35,98% | 18,2 mld. | |
-14,02% | 16,19 mld. | |
+4,61% | 13,72 mld. | |
+35,05% | 12,22 mld. |